Prognostic value of CtIP/RBBP8 expression in breast cancer

CtIP/RBBP8 is a multifunctional protein involved in transcription, DNA replication, DNA repair by homologous recombination and the G1 and G2 checkpoints. Its multiple roles are controlled by its interaction with several specific factors, including the tumor suppressor proteins BRCA1 and retinoblastoma. Both its functions and interactors point to a putative oncogenic potential of CtIP/RBBP8 loss. However, CtIP/RBBP8 relevance in breast tumor appearance, development, and prognosis has yet to be established. We performed a retrospective analysis of CtIP/RBBP8 and RB1 levels by immunohistochemistry using 384 paraffin‐embedded breast cancer biopsies obtained during tumor removal surgery. We have observed that low or no expression of CtIP/RBBP8 correlates with high‐grade breast cancer and with nodal metastasis. Reduction on CtIP/RBBP8 is most common in hormone receptor (HR)‐negative, HER2‐positive, and basal‐like tumors. We observed lower levels of RB1 on those tumors with reduced CtIP/RBBP8 levels. On luminal tumors, decreased but not absence of CtIP/RBBP8 levels correlate with increased disease‐free survival when treated with a combination of hormone, radio, and chemo therapies.

• Publication year

  2013

• Venue

  Cancer Medicine

• Publication date

  2013-10-03

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/cam4.141PMID 24403251PMCID 3892382
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Expression of human BRCA1Δ17-19 alternative splicing variant with a truncated BRCT domain in MCF-7 cells results in impaired assembly of DNA repair complexes and aberrant DNA damage response.

  2013cited by this paper
• CONFLICT OF INTEREST: None declared.

  2013cited by this paper
• Prolyl isomerase PIN1 regulates DNA double-strand break repair by counteracting DNA end resection.

  2013cited by this paper
• RB: mitotic implications of a tumour suppressor

  2012cited by this paper
• Collective evidence supports neutrality of BRCA1 V1687I, a novel sequence variant in the conserved THV motif of the first BRCT repeat

  2012cited by this paper
• The DNA damage response and cancer therapy

  2012cited by this paper
• Transcription as a source of genome instability

  2012cited by this paper
• Modification of BRCA1-Associated Breast and Ovarian Cancer Risk by BRCA1-Interacting Genes.

  2011cited by this paper
• Studies of genomic copy number changes in human cancers reveal signatures of DNA replication stress

  2011cited by this paper
• Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011

  2011cited by this paper
• Hallmarks of cancer: the next generation.

  2011cited by this paper
• Genomic instability — an evolving hallmark of cancer

  2010cited by this paper
• Double strand break repair components are frequent targets of microsatellite instability in endometrial cancer.

  2010cited by this paper
• Expression of PCNA-binding domain of CtIP, a motif required for CtIP localization at DNA replication foci, causes DNA damage and activation of DNA damage checkpoint

  2009cited by this paper
• Multimodal assessment of protein functional deficiency supports pathogenicity of BRCA1 p.V1688del.

  2009cited by this paper
• The DNA-damage response in human biology and disease

  2009cited by this paper
• Modification of ovarian cancer risk by BRCA1/2-interacting genes in a multicenter cohort of BRCA1/2 mutation carriers.

  2009cited by this paper
• Derepression of HMGA2 via Removal of ZBRK1/BRCA1/CtIP Complex Enhances Mammary Tumorigenesis*

  2009cited by this paper
• Breast cancer risk and the BRCA1 interacting protein CTIP

  2008cited by this paper
• Cellular mechanisms of tumour suppression by the retinoblastoma gene

  2008cited by this paper
• Pathogenicity of the BRCA1 missense variant M1775K is determined by the disruption of the BRCT phosphopeptide-binding pocket: a multi-modal approach

  2008cited by this paper
• DNA repair pathways as targets for cancer therapy

  2008cited by this paper
• The functional loss of the retinoblastoma tumour suppressor is a common event in basal-like and luminal B breast carcinomas

  2008cited by this paper
• TRB3 interacts with CtIP and is overexpressed in certain cancers.

  2007cited by this paper
• CtIP Silencing as a Novel Mechanism of Tamoxifen Resistance in Breast Cancer

  2007cited by this paper
• Human CtIP promotes DNA end resection

  2007cited by this paper
• CtIP Activates Its Own and Cyclin D1 Promoters via the E2F/RB Pathway during G1/S Progression

  2006cited by this paper
• BRCA1 ubiquitinates its phosphorylation-dependent binding partner CtIP.

  2006cited by this paper
• Inactivation of CtIP Leads to Early Embryonic Lethality Mediated by G1 Restraint and to Tumorigenesis by Haploid Insufficiency

  2005influential reference
• DNA Damage-Induced Cell Cycle Checkpoint Control Requires CtIP, a Phosphorylation-Dependent Binding Partner of BRCA1 C-Terminal Domains

  2004cited by this paper
• SIAH-1 interacts with CtIP and promotes its degradation by the proteasome pathway

  2003cited by this paper
• Repeated observation of breast tumor subtypes in independent gene expression data sets

  2003cited by this paper
• Mutational analysis of the LMO4 gene, encoding a BRCA1‐interacting protein, in breast carcinomas

  2003cited by this paper
• The LIM Domain Protein LMO4 Interacts with the Cofactor CtIP and the Tumor Suppressor BRCA1 and Inhibits BRCA1 Activity*

  2002cited by this paper
• Screening for microsatellite instability target genes in colorectal cancers

  2002cited by this paper
• Ikaros-CtIP Interactions Do Not Require C-terminal Binding Protein and Participate in a Deacetylase-independent Mode of Repression*

  2002cited by this paper
• A gene-expression signature as a predictor of survival in breast cancer.

  2002cited by this paper
• Predicting the clinical status of human breast cancer by using gene expression profiles

  2001cited by this paper
• Frameshift Mutations at Mononucleotide Repeats in RAD50 Recombinational DNA Repair Gene in Colorectal Cancers with Microsatellite Instability

  2001cited by this paper
• Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns.

  2001cited by this paper
• Nuclear Localization and Cell Cycle-specific Expression of CtIP, a Protein That Associates with the BRCA1 Tumor Suppressor*

  2000cited by this paper
• Loss of heterozygosity at 13q14 correlates with RB1 gene underexpression in human breast cancer

  2000cited by this paper
• Distinctive gene expression patterns in human mammary epithelial cells and breast cancers.

  1999cited by this paper
• Molecular cloning and characterization of a novel retinoblastoma-binding protein.

  1998cited by this paper
• Characterization of a carboxy-terminal BRCA1 interacting protein

  1998cited by this paper
• The C-terminal (BRCT) Domains of BRCA1 Interact in Vivo with CtIP, a Protein Implicated in the CtBP Pathway of Transcriptional Repression*

  1998cited by this paper
• Interaction between a Cellular Protein That Binds to the C-terminal Region of Adenovirus E1A (CtBP) and a Novel Cellular Protein Is Disrupted by E1A through a Conserved PLDLS Motif*

  1998cited by this paper
• Inactivation of the retinoblastoma susceptibility gene in human breast cancers.

  1988cited by this paper

• Distinct prognostic patterns of single hormone receptor-positive subtypes in HER2-negative breast cancer: a SEER-based retrospective cohort study.

  2025cites this paper
• DNA repair and the contribution to chemotherapy resistance

  2025cites this paper
• RBBP8 Is a Prognostic Biomarker Associated With Response to Immune Checkpoint Inhibitors in Advanced Gastric Cancer

  2025cites this paper
• LncRNA LINC01664 promotes cancer resistance through facilitating homologous recombination-mediated DNA repair.

  2024cites this paper
• Development of an obesity-related multi-gene prognostic model incorporating clinical characteristics in luminal breast cancer

  2024cites this paper
• A novel immune checkpoint-related signature for prognosis and immune analysis in breast cancer

  2023cites this paper
• The prognostic significance of human ovarian aging-related signature in breast cancer after surgery: A multicohort study

  2023cites this paper
• DNA binding and bridging by human CtIP in the healthy and diseased states

  2023cites this paper
• A novel RBBP8(p.E281*) germline mutation is a predisposing mutation in familial hereditary cancer syndrome

  2023cites this paper
• Germline RBBP8 variants associated with early-onset breast cancer compromise replication fork stability.

  2020cites this paper
• DNA Damage: From Threat to Treatment

  2020influential citation
• Homologous repair deficiency score for identifying breast cancers with defective DNA damage response

  2020cites this paper
• Multi-Omics Approaches to Study Signaling Pathways

  2020cites this paper
• The Cell-Free Expression of MiR200 Family Members Correlates with Estrogen Sensitivity in Human Epithelial Ovarian Cells

  2020cites this paper
• CtIP-mediated alternative mRNA splicing fine-tunes the DNA damage response

  2020cites this paper
• Human CtIP: A 'double agent' in DNA repair and tumorigenesis.

  2020cites this paper
• An Information Entropy-based Method to Detect microRNA Regulatory Module

  2019cites this paper
• Investigation of the Cell-Cycle Dependent Activity of the BRCA 1-Rbbp 8 Complex for Homologous Recombination 2019

  2019cites this paper
• Exploring the Molecular Mechanism of the Drug-Treated Breast Cancer Based on Gene Expression Microarray

  2019cites this paper
• Regulation of resection by chromatin associated proteins

  2019cites this paper
• Prognosis value of RBBP8 expression in plasma cell myeloma

  2019cites this paper
• CtIP -mediated alternative mRNA splicing finetunes the DNA damage response

  2019cites this paper
• Investigation of the Cell-Cycle Dependent Activity of the BRCA1-Rbbp8 Complex for Homologous Recombination

  2019cites this paper
• Integrative Bioinformatics Approaches to Map Potential Novel Genes and Pathways Involved in Ovarian Cancer

  2019cites this paper
• Promoter methylation of DNA damage repair (DDR) genes in human tumor entities: RBBP8/CtIP is almost exclusively methylated in bladder cancer

  2018cites this paper
• Predicting Disease Genes from Clinical Single Sample-Based PPI Networks

  2018cites this paper
• Genome-wide association study of body weight in Wenshang Barred chicken based on the SLAF-seq technology

  2018influential citation
• CtIP/Ctp1/Sae2, molecular form fit for function.

  2017cites this paper
• Identificación de nuevas proteínas que interaccionan con CtIP: Implicación de PRMT5 y CCAR2 en la resección del ADN

  2017cites this paper
• Computational proteogenomic identification and functional interpretation of translated fusions and micro structural variations in cancer

  2017cites this paper
• The transcription factor GATA3 is required for homologous recombination repair by regulating CtIP expression

  2017cites this paper
• A genome-wide screening uncovers the role of CCAR2 as an antagonist of DNA end resection

  2016cites this paper
• Deletion of 18q is a strong and independent prognostic feature in prostate cancer

  2016cites this paper
• Integrating Multi-omics Data to Dissect Mechanisms of DNA repair Dysregulation in Breast Cancer

  2016cites this paper
• VDAC Differential Interactome in ChickenBrain: Possible Hints to an IntrinsicallyDistinct Metabolism

  2016cites this paper
• A Genome-scale RNA Interference Screen Identifies Novel Regulators of DNA Double-strand Break Repair

  2016cites this paper
• DNA Repair Processes and Checkpoint Pathways in Human Cells Exposed to Heavy Ion Beams.

  2015cites this paper
• CtIP: A DNA damage response protein at the intersection of DNA metabolism.

  2015cites this paper
• Speed matters: How subtle changes in DNA end resection rate affect repair

  2015cites this paper
• Neddylation inhibits CtIP-mediated resection and regulates DNA double strand break repair pathway choice

  2015cites this paper
• High-throughput siRNA Screen in Dendritic Cells to Discover New Genes Regulating Immunologic Tolerance

  2014cites this paper